Quick infos Trade prices Volume: Market Cap: 231.75M Prev closed: 13.24 Open: 13.42 High: 13.65 Low: 12.49 52 week low: 9.01 52 week high: 15.95 Dividends: No Dividends Next ER: September 21, 2022 After Market Closes
Company Profile We are a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical need in the areas of fibrosis, lysosomal storage disorders and oncology.
Earnings History Date EPS / Forecast Revenue / Forecast February 13, 2023 November 10, 2022 - / - - / - September 21, 2022 - / - - / - May 16, 2022 - / - - / - March 7, 2022 -0.67 / -0.734.06M / 2MBeat! view more
Historical Data Date Price Open High Low Vol Change ER Aug 1, 2022 4.65 4.80 4.88
4.65
16.52K -1.9% Jul 29, 2022 4.74 4.82 4.84
4.67
33.02K -1.66% Jul 28, 2022 4.82 4.95 4.99
4.82
5.43K -1.63% Jul 27, 2022 4.90 4.91 4.99
4.90
4.01K 0% Jul 26, 2022 4.90 4.96 5.04
4.90
6.81K -1.21% Jul 25, 2022 4.96 5.09 5.09
4.86
12.42K 2.37% Jul 22, 2022 4.84 4.92 5.15
4.82
25.34K -1.52% Jul 21, 2022 4.92 5.10 5.10
4.90
36.63K -1.99% Jul 20, 2022 5.02 5.20 5.24
5.00
43.79K -2.52% Jul 19, 2022 5.15 5.33 5.38
5.02
42.47K -4.63% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company News
Inventiva Raises 50M Debt Financing To Fund Its Lead Program In NASH Patients finance.yahoo.com Nov 16, 2022 12:24 pm
Results of the votes of the Combined Shareholders Meeting of April 16, 2021 finance.yahoo.com Nov 16, 2022 12:00 pm
Statement of total voting rights and shares forming the companys share capital on March 10th, 2021 finance.yahoo.com Nov 16, 2022 10:43 am
After 10 Years Of Collaboration, AbbVie Discontinues Inventiva-Partnered Psoriasis Candidate finance.yahoo.com Nov 16, 2022 7:50 am
Inventiva reports 2022 Third Quarter Financial Information¹ finance.yahoo.com Nov 10, 2022 4:00 pm
Inventiva announces a scientific presentation at the AASLD The Liver Meeting® 2022 finance.yahoo.com Oct 21, 2022 4:00 pm
Inventiva Inks Licensing Pact With China-Based Sino Biopharm For NASH Candidate In Greater China finance.yahoo.com Sep 22, 2022 7:27 am Inventiva, Sino Biopharm sign licensing pact to develop, commercialize NASH treatment seekingalpha.com Sep 22, 2022 5:02 am
Inventiva announces the schedule of publication and presentation of its 2022 Half-Year Financial Results finance.yahoo.com Sep 7, 2022 4:00 pm
Here's Why Inventiva S.A. Sponsored ADR (IVA) Could be Great Choice for a Bottom Fisher finance.yahoo.com Jun 15, 2022 9:55 am Inventiva reports Q1 results seekingalpha.com May 17, 2022 4:47 am Inventiva gets FDA nod to begin phase 2 trial to treat diabetes/liver disease seekingalpha.com Mar 8, 2022 6:21 pm
Inventiva announces the schedule of publication and presentation of its 2021 Full-Year Financial Results finance.yahoo.com Feb 28, 2022 4:00 pm
Inventiva reports cash position and revenues for Full-Year 2021 finance.yahoo.com Feb 14, 2022 4:00 pm
Inventiva and Sino Biopharm announce licensing and collaboration agreement to develop and commercialize lanifibranor in Greater China finance.yahoo.com Sep 21, 2022 4:40 pm
Half-Year Review of Inventivas Liquidity Contract with Kepler Cheuvreux finance.yahoo.com Jul 21, 2022 12:00 pm
Update on Inventiva's cash position and on the finance documentation with the European Investment Bank finance.yahoo.com Jul 4, 2022 12:45 pm
Inventiva joins the Euronext Tech Leaders segment finance.yahoo.com Jun 7, 2022 4:00 pm
Inventiva announces participation at several investors conferences in May and June 2022 finance.yahoo.com May 23, 2022 4:00 pm
Description of the Share Repurchase Program Authorised by the Ordinary General Meeting of 19 May 2022 finance.yahoo.com May 19, 2022 4:00 pm This company doesn't provide a dividend.
Talk about Inventiva ADR below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.
The best book on investing ever written.
